Navis Capital Partners may invest $28.5 million in Twilight Litaka Pharma - MarketLine Financial Deals

Navis Capital Partners may invest $28.5 million in Twilight Litaka Pharma

Navis Capital Partners may invest $28.5 million in Twilight Litaka Pharma - MarketLine Financial Deals
Navis Capital Partners may invest $28.5 million in Twilight Litaka Pharma
Published Apr 30, 2012
2 pages — Published Apr 30, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

According to Business Standard, Navis Investment Partners (Asia) Limited, a Malaysia-based private equity firm, is in talks to invest approximately INR1,500 million ($28.5 million) in Twilight Litaka Pharma, Ltd., a India-based manufacturer of drugs and formulations in the form of tablets, capsules, ointment and liquids.

  
Source:
Document ID
MA108249_120503
Country
Ticker
506985=IN
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Navis Capital Partners may invest $28.5 million in Twilight Litaka Pharma" Apr 30, 2012. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Navis-Capital-Partners-may-invest-28-5-million-in-Twilight-Litaka-Pharma-2052-80989>
  
APA:
MarketLine Financial Deals. (2012). Navis Capital Partners may invest $28.5 million in Twilight Litaka Pharma Apr 30, 2012. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Navis-Capital-Partners-may-invest-28-5-million-in-Twilight-Litaka-Pharma-2052-80989>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.